Increasing drug resistance of Mycobacterium tuberculosis in Sinaloa, Mexico, 1997-2005

International Journal of Infectious Diseases

Volumn 15, Issue 4, 2011, Pages

  Zazueta Beltran, Jorge ^a,b   León Sicairos, Nidia ^a,c   Muro Amador, Secundino ^b   Flores Gaxiola, Adrian ^d   Velazquez Roman, Jorge ^a   Flores Villaseñor, Hector ^a   Canizalez Roman, Adrian ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE SINALOA   (Mexico)

^b The Sinaloa State Public Health Laboratory   (Mexico)

^c HOSPITAL DE PEDIATRÍA   (Mexico)

^d ISSSTE Hospital   (Mexico)

Author keywords

First line anti TB drugs; Trends; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SCHOOL CHILD; SPUTUM ANALYSIS; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CHILD; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MEXICO; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 79952701349     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.01.001     Document Type: Article

References (28)

1. Espinal M.A., Laszlo A., Simonsen L., Boulahbal F., Kim S.J., Reniero A., et al. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Wo rking Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001, 344:1294-1303.
2. Gupta R., Espinal M.A., Raviglione M.C. Tuberculosis as a major global health problem in the 21st century: a WHO perspective. Semin Respir Crit Care Med 2004, 25:245-253.
3. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 2002-2007. Anti-tuberculosis drug resistance in the world. Report No. 4. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO; 2008.
4. Zazueta-Beltran J., Leon-Sicairos C., Canizalez-Roman A. Drug resistant Mycobacterium tuberculosis in Mexico. J Infect Dev Ctries 2009, 3:162-168.
5. World Health Organization. WHO report on the tuberculosis epidemic. WHO/TB/97/224. Geneva, Switzerland: WHO; 1997.
6. Dye C., Lonnroth K., Jaramillo E., Williams B.G., Raviglione M. Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ 2009, 87:683-691.
7. Caminero J.A. Management of multidrug-resistant tuberculosis and patients in retreatment. Eur Respir J 2005, 25:928-936.
8. Caminero J.A. Treatment of multidrug-resistant tuberculosis: evidence and controversies. Int J Tuberc Lung Dis 2006, 10:829-837.
9. Caminero Luna J.A. [Origin, present, and future of tuberculosis resistance] (in Spanish). Arch Bronconeumol 2001, 37:35-42.
10. Frieden T.R., Sterling T., Pablos-Mendez A., Kilburn J.O., Cauthen G.M., Dooley S.W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993, 328:521-526.
11. Garcia-Garcia M.L., Jimenez-Corona M.E., Ponce-de-Leon A., Jimenez-Corona A., Palacios-Martinez M., Balandrano-Campos S., et al. Mycobacterium tuberculosis drug resistance in a suburban community in southern Mexico. Int J Tuberc Lung Dis 2000, 4:S168-S170.
12. García-García M.L., Sifuentes-Osornio J., Jiménez-Corona M.E., Ponce-de-León A., Jiménez-Corona A., Bobadilla-del Valle M., et al. Drug resistance of Mycobacterium tuberculosis in Orizaba, Veracruz. Implications for the tuberculosis prevention and control program] (in Spanish). Rev Invest Clin 2001, 53:315-323.
13. Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006;55:301-5.
14. Pablos-Mendez A., Raviglione M.C., Laszlo A., Binkin N., Rieder H.L., Bustreo F., et al. Global surveillance for antituberculosis drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Gro up on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 1998, 338:1641-1649.
15. WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world. Report 2: Prevalence and trends. WHO/CDC/TB/2000.278. Geneva, Switzerland: WHO; 2000.
16. WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 1999-2002. Anti-tuberculosis drug resistance in the world. Report No. 3. WHO/CDC/TB/2004.343. Geneva, Switzerland: WHO; 2004.
17. Baez-Saldana A.R., Perez-Padilla J.R., Salazar-Lezama M.A. [Epidemiology of tuberculosis in Mexico, 1981-1998. Inconsistencies between reports of the WHO and the Ministry of Health] (in Spanish). Salud Publica Mex 2003, 45:78-83.
18. Granich R.M., Balandrano S., Santaella A.J., Binkin N.J., Castro K.G., Marquez-Fiol A., et al. Survey of drug resistance of Mycobacterium tuberculosis in 3 Mexican states, 1997. Arch Intern Med 2000, 160:639-644.
19. Department of Health. Sistema Unico de Información para la Vigilancia Epidemiológica/Dirección General de Epidemiología/SSA. Mexico: Department of Health; 2010. Available at: (accessed January 11, 2010). http://www.dgepi.salud.gob.mx/.
20. Zazueta-Beltran J., Muro-Amador S., Flores-Gaxiola A., Llausas-Magana E., Leon-Sicairos N., Canizalez-Roman A. High rates of multidrug-resistant Mycobacterium tuberculosis in Sinaloa State, Mexico. J Infect 2007, 54:411-412.
21. Blancarte M.L., Anzaldo J.G., Balandrano S.S. [Primary resistance of Mycobacterium tuberculosis] (in Spanish). Salud Publica Mex 1982, 24:321-327.
22. Fragoso Morales L.E., Pastor Durango P., Magana Aquino M., Fajardo Santana H., Bobadilla de Valle M., Carrera de la Torre B., et al. [Risk factors for drug-resistant tuberculosis in San Luis Potosi, Mexico 2003-2004] (in Spanish). Salud Publica Mex 2006, 48:361-362.
23. Laniado-Laborin R., Cabrales-Vargas N. Tratamiento acortado estrictamente supervisado: Estrategia necesaria, pero no suficiente para controlar la tuberculosis en Baja, California, México. Rev Inst Nal Enf Resp Mex 2000, 13:23-27.
24. Olvera Castillo R. Farmacorresistencia secundaria en tuberculosis. Tendencia en el Instituto Nacional de Enfermedades Respiratorias. Rev Inst Nal Enf Resp Mex 2001, 14:151-159.
25. Sifuentes Osornio J. Epidemiología de la resistencia antimicrobiana en Mycobacterium tuberculosis en México. Gac Méd Méx 2003, 139:477-480.
26. Alvarez-Gordillo G.C., Halperin-Frisch D., Blancarte-Melendres L., Vazquez-Castellanos J. [Risk factors for antitubercular drug resistance in Chiapas, Mexico] (in Spanish). Salud Publica Mex 1995, 37:408-416.
27. Peter C.R., Schultz E., Moser K., Cox M., Freeman R., Ramirez-Zetina M., Lomeli M.R. Drug-resistant pulmonary tuberculosis in the Baja California-San Diego County border population. West J Med 1998, 169:208-213.
28. Secretaría de Salud. Modificación a la Norma Oficial Mexicana NOM-006-SSA2-1993. Para la prevención y control de la tuberculosis en la atención primaria a la salud. Diario Oficial de la Federación, 2000; Octubre: 9-33. Ministry of Health: Mexico; 2000.